Abstract
Cedar Trial in Progress: A First in Human, Phase 1/2 Study of the Correction of a Single Nucleotide Mutation in Autologous HSCs (GPH101) to Convert HbS to HbA for Treating Severe SCD
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have